Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Lyme Wars: time to listen.

Raphael B Stricker1, Andrew Lautin

  • 1Department of Medicine, California Pacific Medical Center, 450 Sutter Street, Suite 1504, San Francisco, CA, USA. rstricker@usmamed.com

Expert Opinion on Investigational Drugs
|October 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing Exclusion Criteria for Clinical Trials of Persistent Lyme Disease Using Real-World Data.

Healthcare (Basel, Switzerland)·2025
Same author

Does Biological Sex Matter in Lyme Disease? The Need for Sex-Disaggregated Data in Persistent Illness.

International journal of general medicine·2023
Same author

Role of hydroxychloroquine in multidrug treatment of COVID-19.

Reviews in cardiovascular medicine·2021
Same author

Hydroxychloroquine Pre-Exposure Prophylaxis for COVID-19 in Healthcare Workers from India: A Meta-Analysis.

Journal of infection and public health·2021
Same author

Dermatological and Genital Manifestations of Lyme Disease Including Morgellons Disease.

Clinical, cosmetic and investigational dermatology·2021
Same author

Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women.

International journal of general medicine·2021

Lyme disease, caused by Borrelia burgdorferi, presents diagnostic and treatment challenges due to co-infections and persistent bacteria. Effective treatment may require prolonged combination therapy for complex cases.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Microbiology

Background:

  • Lyme disease is a significant public health concern with complex scientific and political challenges hindering diagnosis and treatment.
  • Key issues include the lack of a clear therapeutic endpoint for Borrelia burgdorferi infections and the impact of tick-borne co-infections (babesiosis, anaplasmosis, bartonellosis).

Purpose of the Study:

  • To highlight the clinical complexity of Lyme disease.
  • To discuss challenges in treating Borrelia burgdorferi infections.
  • To emphasize the role of co-infections in Lyme disease progression.

Main Methods:

  • Review of existing literature on Lyme disease pathophysiology and treatment.
  • Analysis of clinical challenges including diagnostic difficulties and treatment failures.

Related Experiment Videos

  • Consideration of pathophysiological factors contributing to persistent infection.

    • Main Results:

    • Borrelia burgdorferi exhibits affinity for multiple cell types and can exist in non-replicating forms, leading to persistent infections.
    • Simple antibiotic regimens often fail due to the complex nature of the spirochete and potential co-infections.
    • Co-infections complicate the illness course and treatment efficacy.

    Conclusions:

    • Newer Lyme disease treatment strategies must address clinical complexity, co-infections, and potential need for prolonged combination therapy.
    • Further research is needed on the risk and prevention of human transmission of Lyme disease.
    • Persistent symptoms may necessitate extended treatment regimens for debilitating Lyme disease cases.